XANTHUS
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Aug 2007)
What this means for you
This application is over — abandoned 27 Aug 2007. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 76275239
- Mark type
- Word mark
- Filed
- 21 Jun 2001
- Published for opposition
- 01 Jul 2003
- Abandoned
- 27 Aug 2007
- Attorney of record
- Michael J. Bevilacqua, Esquire
Goods and services
- Class 005 — Pharmaceuticals: Medical test kits consisting primarily of human diagnostic assays for use in determining the suitability of treatments; and pharmaceuticals for use in the treatment of neurological disorders, psychiatric illnesses, tuberculosis, malaria, epilepsy, autoimmune disease, HIV/AIDS, obesity, diabetes, viruses, allergies, transplant patients, gasteroenterological disorders, sexual dysfunction, pain, infection, and depression, and for use in anesthesia
- Class 042 — Scientific and technological services: Providing medical diagnostic services, analysis of patient populations, analysis of drug study data, development of drugs for others; and providing databases in the field of medicine
Owner
- XANTHUS PHARMACEUTICALS, INC., CAMBRIDGE, MA, US
- Xanthus Life Sciences, Inc., Cambridge, MA, US
- Xanthus Life Sciences, Inc., Cambridge, MA, US
Prosecution history
- 15 Jan 2008 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 15 Jan 2008 — ABANDONMENT - NO USE STATEMENT FILED
- 30 Jan 2007 — SOU EXTENSION 5 GRANTED
- 30 Jan 2007 — SOU EXTENSION 5 FILED
- 30 Jan 2007 — SOU TEAS EXTENSION RECEIVED
- 31 Aug 2006 — DIVISIONAL PROCESSING COMPLETE
- 28 Jul 2006 — DIVISIONAL REQUEST RECEIVED
- 28 Jul 2006 — PAPER RECEIVED
- 25 Jul 2006 — SOU EXTENSION 4 GRANTED
- 14 Jul 2006 — SOU EXTENSION 4 FILED
- 26 Jul 2006 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Jul 2006 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2006 — SOU EXTENSION 3 GRANTED
- 16 Feb 2006 — SOU EXTENSION 3 FILED
- 16 Feb 2006 — SOU TEAS EXTENSION RECEIVED